Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-04 Sale | 2023-10-06 7:19 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer | 10,628 | $19.5 | $207,298 | 105,685 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-21 Option Award | 2024-06-21 5:59 pm | N/A 2034-06-21 | Shattuck Labs Inc. | STTK | Brownstein Carrie Director | 27,700 | $0 | 27,700 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 4:36 pm | N/A 2033-05-26 | Shattuck Labs Inc. | STTK | Brownstein Carrie Director | 40,258 | $0 | 40,258 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:06 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer | 40,000 | $0 | 140,000 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-03 6:37 pm | N/A 2032-10-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer | 400,000 | $0 | 500,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:31 pm | N/A 2032-06-08 | Shattuck Labs Inc. | STTK | Brownstein Carrie Director | 40,258 | $0 | 40,258 (Direct) | View |
| 2021-11-12 Option Award | 2021-11-17 4:10 pm | N/A 2031-11-12 | Shattuck Labs Inc. | STTK | Brownstein Carrie Director | 10,467 | $0 | 10,467 (Direct) | View |